The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology

Iron Overload Management: Potential for Improved Survival in Patients with MDS

New Orleans, Louisiana / December 5-8, 2009

New Orleans - A series of studies have underscored the importance of evaluating and treating iron overload in selected patients with myelodysplastic syndrome (MDS), including one that reinforces the likelihood of a survival advantage if...

PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology

Enhanced Directives for Anticoagulation in Cancer Patients

New Orleans, Louisiana / December 5-8, 2009

New Orleans - Prophylaxis for venous thromboembolism (VTE) has now been endorsed for hospitalized cancer patients without a bleeding contraindication by a broad array of influential medical organizations, including the American Society of...

PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology

New Strategies for Identifying Anti-FVIII Antibodies in Patients with Hemophilia

New Orleans, Louisiana / December 5-8, 2009

New Orleans - In patients with hemophilia, new and more sensitive strategies for identifying factor VIII (FVIII) antibodies may better characterize the immune response that often defeats recombinant FVIII therapies. The standard test has...

PRIORITY PRESS - 51st Annual Meeting of the American Society of Hematology

Optimizing Multiple Myeloma Induction and Maintenance Therapies in the Elderly

New Orleans, Louisiana / December 5-8, 2009

New Orleans - The standard of care for the treatment of multiple myeloma (MM) in elderly patients, who cannot usually tolerate high-dose therapy, was recently revised from a two-drug combination of melphalan and prednisone (MP) to a...

MEDICAL FRONTIERS - XXII Congress of the International Society on Thrombosis and Haemostasis

VTE Treatment and Prophylaxis: Strategies for Improved Intervention

Boston, Massachusetts / July 11-16, 2009

Boston - Thromboprophylaxis is considered a high priority safety intervention in hospitalized patients. In patients with cancer, the incidence and recurrence of venous thromboembolism (VTE) are more common. While several studies have...

PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the Toronto Myelodysplastic Syndromes Symposium: Progress and Challenges

Pathophysiology of Myelodysplastic Syndromes and Treatment Strategies to Change its Natural History

Toronto, Ontario / May 21-22, 2009

INTRODUCTION Treating patients with myelodysplastic syndromes (MDS) beyond supportive care has become a viable goal. As the pathobiology of MDS is unravelled, new therapies become available to treat these complex bone marrow failure...

MEDICAL FRONTIERS - 35th Annual Meeting of the European Group for Blood and Marrow Transplantation

Secondary Prevention of Invasive Fungal Infections in Stem-cell Transplant Patients

Göteborg, Sweden / March 29-April 1, 2009

Göteborg - The risk of recurrence of a previous invasive fungal infection (IFI) or acquisition of a new one is a major obstacle to the success of stem-cell transplantation (SCT). These infections are increasing in frequency and the majority...

PRIORITY PRESS - 50th Annual Meeting and Exhibition of the American Society of Hematology

New Options in VTE Prophylaxis in the Surgical Setting

San Francisco, California / December 6-9, 2008

San Francisco - Major orthopedic surgery, such as total hip or knee replacement, confers a recognized risk of venous thromboembolism (VTE), including deep-vein thrombosis and pulmonary embolism. To prevent VTE, clinicians traditionally have...

PRIORITY PRESS - Critical Care Canada Forum

Echinocandins in the ICU: A Clinical Advance

Toronto, Ontario / November 11-13, 2008

Invasive and septic Candida infections are associated with high levels of mortality and morbidity. However, the agents most commonly used to empirically treat these pathogens are associated with significant drawbacks: there are now high...

PAGE 6 OF 9   1 2 3 4 5 6 7 8 9